Searched for
HYPERTENSION DRUGS
The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...
These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
If you do this 800-year-old Chinese exercise daily, your BP & heart may stay healthier than with any other medicine, says studyChinese exercise: An ancient Chinese exercise, Baduanjin, practiced for centuries, shows promise in managing high blood pressure. New resea...
No gym, no equipment, no sweat: This 800-year-old Chinese exercise is quietly fixing high blood pressureAn 800-year-old Chinese exercise once practiced quietly in parks and public squares is now drawing global attention after scientists discov...
Paracetamol may get costlier as Vizag chemists warn 30–40% drug cost surge amid Iran war-led pharma cost shockThe ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for es...
Alembic Pharma gets USFDA nod for generic cancer, arthritis injectionAlembic Pharmaceuticals has received final approval from the US Food and Drug Administration for its generic methotrexate injection, used t...
Cipla gets USFDA nod for pulmonary arterial hypertension drugCipla said the US sales of Letairis tablets USP stood at USD 943 million in 2018.
Torrent Pharma recalls over 10.78 lakh bottles of hypertension drug from USThe US-based arm of Torrent Pharmaceuticals is recalling 133,992 bottles of Losartan Potassium tablets USP in the strength of 25 mg.
Aurobindo recalls hypertensive drug in US citing cancer riskScieGen Pharmaceuticals has initiated recall of the finished Irbesartan drug from the market, a separate notification by the FDA said.
Lupin launches generic hypertension drug in US marketThe Mumbai-based company's product is the generic equivalent of Daiichi Sankyo Inc's Benicar tablets which is indicated for the treatment o...
Cadila Healthcare recalls 15,144 bottles of hypertension drug in USAs per information available on the USFDA website, Zydus Pharmaceuticals USA Inc, the US-based arm of the company, is recalling the drug du...
- Lupin gets USFDA nod for generic hypertension drug
Lupin today said it has received US health regulator's approval to market generic version of Novartis Pharmaceuticals Corp's Diovan HCT Tab...
- Unichem Labs gets USFDA approval for hypertension drug
Irbesartan tablets are indicated for the treatment of hypertension and are therapeutically equivalent to Sanofi Aventis' Avapro tablets, it...
- Ranbaxy to launch anti-hypertensive drug in Africa
Ranbaxy Laboratories will launch parent company Daiichi Sankyo’s anti-hypertensive drug, Olmesartan Medoxomil, in six African countries und...
- Sun Pharma subsi gets USFDA nod for anti-hypertension drug
Drug firm Sun Pharmaceutical Industries on Wednesday said that its subsidiary, has received US Drug regulator approval for anti-hypertensio...
- Aurobindo gets Australia nod for anti-hypertension drugs
Drug maker Aurobindo Pharma said on Monday that its Australian subsidiary has received approval from the government agency for registering ...